Universe Pharmaceuticals (UPC) Long-Term Deferred Tax: 2020-2023

Historic Long-Term Deferred Tax for Universe Pharmaceuticals (UPC) over the last 4 years, with Sep 2023 value amounting to $599,078.

  • Universe Pharmaceuticals' Long-Term Deferred Tax fell 55.55% to $599,078 in Q3 2023 from the same period last year, while for Sep 2023 it was $599,078, marking a year-over-year decrease of 55.55%. This contributed to the annual value of $599,078 for FY2023, which is 55.55% down from last year.
  • Latest data reveals that Universe Pharmaceuticals reported Long-Term Deferred Tax of $599,078 as of FY2023, which was down 55.55% from $1.3 million recorded in FY2022.
  • In the past 5 years, Universe Pharmaceuticals' Long-Term Deferred Tax registered a high of $186.5 billion during FY2020, and its lowest value of $599,078 during FY2023.
  • For the 3-year period, Universe Pharmaceuticals' Long-Term Deferred Tax averaged around $938,916, with its median value being $869,997 (2021).
  • Its Long-Term Deferred Tax has fluctuated over the past 5 years, first crashed by 100.00% in 2021, then skyrocketed by 54.91% in 2022.
  • Yearly analysis of 4 years shows Universe Pharmaceuticals' Long-Term Deferred Tax stood at $186.5 billion in 2020, then crashed by 100.00% to $869,997 in 2021, then soared by 54.91% to $1.3 million in 2022, then plummeted by 55.55% to $599,078 in 2023.